• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
JIANG Yuqiu, TANG Qiaofei, ZHANG Shuang, YAN Zhiyong. Combined effects of gallic acid and ciprofloxacin on the murine chronic rhinosinusitis model in mice[J]. Journal of China Pharmaceutical University, 2015, 46(5): 600-604. DOI: 10.11665/j.issn.1000-5048.20150514
Citation: JIANG Yuqiu, TANG Qiaofei, ZHANG Shuang, YAN Zhiyong. Combined effects of gallic acid and ciprofloxacin on the murine chronic rhinosinusitis model in mice[J]. Journal of China Pharmaceutical University, 2015, 46(5): 600-604. DOI: 10.11665/j.issn.1000-5048.20150514
shu

Combined effects of gallic acid and ciprofloxacin on the murine chronic rhinosinusitis model in mice

More Information
    Graphical Abstract
    • Abstract
  • This study aimed to detect the combined effects of gallic acid(GA)and ciprofloxacin(CIP)on the murine chronic rhinosinusitis(CRS)model in mice. Pseudomonas aeruginosa from refractory CRS nasal samples were isolated and a CRS model in mice was induced. GA and CIP were intragastrically administered singly or in combination. The nasal histopathologic change was observed by hematoxylin and eosin(HE)staining. The concentration of TNF-α, IL-6 and IL-8 in serum were determined by ELISA assay. The activity of SOD and contents of MDA and ROS were measured with commercially available kits. The expressions of IκB, NF-κB p65, TNF-α, IL-6 and IL-8 in nasal mucosa tissues were measured by Western blotting assay. The results showed that the inflammation of CRS in each treatment group was significantly attenuated. The expression level of TNF-α, IL-6, IL-8, MDA, NF-κB p65 and the contents of ROS were reduced significantly in treated groups, while the activity of SOD and the expression level of IκB were increased. More obvious effects were achieved in CA and CIP combined group. The data showed that combination of GA and CIP was superior to GA or CIP alone, and the combined therapy might be related with inhibiting NF-κB signaling pathway and downregulating the expressions of TNF-α, IL-6 and IL-8.
    • FullText(HTML)
    • References (19)
  • [1]
    Hamilos DL.Chronic rhinosinusitis:epidemiology and medical management[J].J Allergy Clin Immunol,2011,128(4):693-707.
    [2]
    Dykewicz MS,Hamilos DL.Rhinitis and sinusitis[J].J Allergy Clin Immunol,2010,125(2 Suppl 2):S103-115.
    [3]
    Wu KQ.Antitumor activity and mechanism of saikosaponin D combined with oxaliplatin on A549 cells- bearing nude mice[J].J China Pharm Univ(中国药科大学学报),2015,46(3):355-358.
    [4]
    Lee DS,Eom SH,Kim YM,et al.Antibacterial and synergic effects of gallic acid-grafted-chitosan with beta-lactams against methicillin-resistant Staphylococcus aureus(MRSA)[J].Can J Microbiol,2014,60(10):629-638.
    [5]
    Alkan D, Aydemir LY, Arcan I, et al. Development of flexible antimicrobial packaging materials against Campylobacter jejuni by incorporation of gallic acid into zein-based films[J].J Agric Food Chem,2011,59(20):11003-11010.
    [6]
    Choi HJ,Song JH,Bhatt LR,et al.Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity[J].Phytother Res,2010,24(9):1292-1296.
    [7]
    Verma S,Singh A,Mishra A.Gallic acid:molecular rival of cancer[J].Environ Toxicol Pharmacol,2013,35(3):473-485.
    [8]
    Hsu JD,Kao SH,Ou TT,et al.Gallic acid induces G2/M phase arrest of breast cancer cell MCF-7 through stabilization of p27(Kip1)attributed to disruption of p27(Kip1)/Skp2 complex[J].J Agric Food Chem,2011,59(5):1996-2003.
    [9]
    You BR,Moon HJ,Han YH,et al.Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis[J].Food Chem Toxicol,2010,48(5):1334-1340.
    [10]
    Pal C, Bindu S, Dey S, et al. Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis[J].Free Radic Biol Med,2010,49(2):258-267.
    [11]
    Jayamani J,Shanmugam G.Gallic acid,one of the components in many plant tissues,is a potential inhibitor for insulin amyloid fibril formation[J].Eur J Med Chem,2014,85:352-358.
    [12]
    Shahrzad S,Aoyagi K,Winter A,et al.Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans[J].J Nutr,2001,131(4):1207-1210.
    [13]
    The National Clinical Test Regulation of Operation(全国临床检验操作规程)[M].Nanjing:Southeast University Press,2006:290.
    [14]
    Jacob A,Faddis BT,Chole RA.Chronic bacterial rhinosinusitis:description of a mouse model[J].Arch Otolaryngol Head Neck Surg,2001,127(6):657-664.
    [15]
    Danielsen KA,Eskeland O,Fridrich-Aas K,et al.Bacterial biofilms in patients with chronic rhinosinusitis:a confocal scanning laser microscopy study[J].Rhinology,2014,52(2):150-155.
    [16]
    Al-Mutairi D,Kilty SJ.Bacterial biofilms and the pathophysiology of chronic rhinosinusitis[J].Curr Opin Allergy Clin Immunol,2011,11(1):18-23.
    [17]
    Du J,Zhao CY,Wang X.Research progresses on the pathogenesis of bacterial biofilm in chronic rhinosinusitis[J].J Clin Otorhinol Head Neck Surg(临床耳鼻咽喉头颈外科杂志),2013,27(8):446-448.
    [18]
    Masak J,Cejkova A,Schreiberova O,et al.Pseudomonas biofilms:possibilities of their control[J].FEMS Microbiol Ecol,2014,89(1):1-14.
    [19]
    Xiao J,Duan X,Yin Q,et al.The inhibition of metastasis and growth of breast cancer by blocking the NF-kappaB signaling pathway using bioreducible PEI-based/p65 shRNA complex nanoparticles[J].Biomaterials,2013,34(21):5381-5390.
    • Related Articles

  • Related Articles

    [1]YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202
    [2]YONG Qin, YUE Hanxun, SHI Min, HUANG Shiqin, ZHAO Xuan, YU Xian. Construction and in vitro evaluation of pH-responsive and tumor-targeted PTEN/PLGA-(HE)10-MAP nanoparticles[J]. Journal of China Pharmaceutical University, 2021, 52(3): 301-310. DOI: 10.11665/j.issn.1000-5048.20210306
    [3]FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406
    [4]SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402
    [5]FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302
    [6]SUN Jingfang, GUO Chunjing, ZHANG Yunduan, SONG Xiaoyan, LYU Jiantao, YIN Jungang, CHEN Daquan. Preparation and characterization of multi-functional targeting nano-carrier based on pH-redox tumor microenvironment[J]. Journal of China Pharmaceutical University, 2017, 48(3): 305-310. DOI: 10.11665/j.issn.1000-5048.20170309
    [7]HE Wei, QI Haixia, DONG Lei, ZHANG Junfeng. Research advances in drug delivery system targeting immune system[J]. Journal of China Pharmaceutical University, 2015, 46(5): 513-520. DOI: 10.11665/j.issn.1000-5048.20150501
    [8]ZHANG Zhiqing, WANG Fang, ZHOU Ting, ZHANG Guodong, WANG Xiufeng, LI Yunze. A DNA polyaptamer system as a targeted antitumor drug delivery[J]. Journal of China Pharmaceutical University, 2015, 46(4). DOI: 10.11665/j.issn.1000-5048.20150408
    [9]SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103
    [10]KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15.

Catalog

    Get Citation
    PDF
    XML
    Article views (1118) PDF downloads (2050) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：327247

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return